Notably, we showed that macrophage Foxo1 cooperated with the YAP and Notch1 signaling pathways to control NASH progression by modulating cGAS-STING-mediated innate immune responses (Supplementary Fig. 1). The gene discussed is FOXO1; the disease is metabolic dysfunction-associated steatohepatitis.